Levosert Single-Handed Inserter

Levonorgestrel, the active ingredient in Levosert Single-Handed Inserter, is a progestin presented as a hormonal intrauterine system for intrauterine use. It provides long‑acting reversible contraception by continuously releasing levonorgestrel within the uterus.

GNH USA supplies Levosert Single-Handed Inserter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levosert Single-Handed Inserter, containing levonorgestrel, acts within the hormonal contraceptive pathway to prevent pregnancy.

Long‑acting reversible contraception: provides up to five years of highly effective pregnancy protection. Prevention of unintended pregnancy: reduces the risk of conception for women of reproductive age. Management of heavy menstrual bleeding: can lessen menstrual blood loss and improve cycle regularity.

Levosert may be associated with a range of adverse reactions, most of which are related to the intrauterine device and local hormone exposure.

Common Side Effects: - Irregular vaginal bleeding or spotting - Amenorrhea (absence of periods) after initial months - Pelvic or cramping pain at insertion - Discomfort or soreness at the insertion site

Serious or Rare Side Effects: - Uterine perforation during insertion - Expulsion of the intrauterine system - Pelvic inflammatory disease or infection - Ectopic pregnancy if contraception fails

Before prescribing Levosert, clinicians should consider several precautionary measures to ensure patient safety.

Screen for contraindications: confirm absence of active pelvic infection, uterine anomalies, or current pregnancy. Assess thromboembolic risk: avoid in women with a history of clotting disorders unless benefits outweigh risks. Monitor bleeding patterns: counsel patients about possible changes in menstrual flow after insertion. Verify device position: schedule follow‑up examination if abnormal symptoms such as pain or missing strings occur. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levosert can interact with other medicines that affect hormone metabolism or uterine environment.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce levonorgestrel levels and contraceptive efficacy. - Rifampicin or rifampin‑containing regimens: can lower hormone concentrations, increasing risk of unintended pregnancy.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline: may slightly diminish hormonal effect; advise additional contraceptive method. - Azole antifungals (e.g., ketoconazole): may increase levonorgestrel exposure, potentially enhancing side effects. - Herbal supplements like St. John’s wort: can accelerate hormone metabolism, reducing effectiveness.